Back to Trades
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.CIK 0001816676
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Rajangam Kanya, Pres. & Chief Med. & Dev. Off., has filed 2 SEC reports (2026), all concentrated in Senti Biosciences Holdings, Inc. (SNTI), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 23 | SNTI Senti Biosciences Holdings, Inc. | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Tax withheld | $0 |
| Feb 3 | SNTI Senti Biosciences, Inc. | Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | Tax withheld | $0 |
2 filings